SCHEMBL4602103

SCHEMBL4602103

CC(c1ccccc1)N1CC=C(c2ccc(OCc3ccccc3)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.49
CHRM4 P08173 1/20 0.47
FDFT1 P37268 1/20 0.44
S1PR1 P21453 2/20 0.43
S1PR5 Q9H228 1/20 0.43
BCHE P06276 1/20 0.43
PRMT5 O14744 2/20 0.42
S1PR3 Q99500 1/20 0.42
FFAR1 O14842 1/20 0.42
NPC1 O15118 2/20 0.41
TP53 P04637 2/20 0.41
ESRRB O95718 1/20 0.41
ESR1 P03372 1/20 0.41
ESRRG P62508 1/20 0.41
KCNH2 Q12809 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602100 1.00 HRH3 (0.49) HRH3CHRM4FDFT1S1PR1S1PR5
SCHEMBL8218213 0.78 FDFT1 (0.47) CHRM4FDFT1S1PR5BCHENPC1
SCHEMBL8218218 0.78 FDFT1 (0.47) CHRM4FDFT1S1PR5BCHENPC1
SCHEMBL1941467 0.78 FDFT1 (0.47) CHRM4FDFT1S1PR5BCHENPC1
SCHEMBL6622776 0.77 FDFT1 (0.44) HRH3CHRM4FDFT1BCHENPC1
SCHEMBL4083380 0.76 FDFT1 (0.46) HRH3CHRM4FDFT1BCHEPRMT5
SCHEMBL4083377 0.76 FDFT1 (0.46) HRH3CHRM4FDFT1BCHEPRMT5
SCHEMBL2682972 0.76 FDFT1 (0.46) HRH3CHRM4FDFT1BCHEPRMT5
SCHEMBL8214501 0.76 NPC1 (0.56) HRH3S1PR1S1PR3FFAR1NPC1
SCHEMBL5128246 0.76 HRH3 (0.60) HRH3CHRM4S1PR1S1PR5PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979819-B1 Process for the production of substituted 3-hydroxypiperidines SPEEDEL PHARMA AG (CH) 2008-04-23 EP claimed
EP-0979824-B1 Process for the preparation of substituted piperidine-epoxides HOFFMANN LA ROCHE (CH) 2004-10-06 EP claimed
EP-0979824-A1 Process for the preparation of substituted piperidine-epoxides F. HOFFMANN-LA ROCHE AG (CH) 2000-02-16 EP claimed
EP-0979819-A1 Process for the production of substituted 3-hydroxypiperidines F. HOFFMANN-LA ROCHE AG (CH) 2000-02-16 EP claimed
EP-0979819-B1 Process for the production of substituted 3-hydroxypiperidines SPEEDEL PHARMA AG (CH) 2008-04-23 EP disclosed
EP-0979824-B1 Process for the preparation of substituted piperidine-epoxides HOFFMANN LA ROCHE (CH) 2004-10-06 EP disclosed
CN-1161335-C Method for preparing substituted piperidine - 2004-08-11 CN disclosed
CN-1111534-C Method for preparing substituted piperidine-epoxide HOFFMANN LA ROCHE (CH) 2003-06-18 CN disclosed
US-6274735-B1 RENIN INHIBITORS HOFFMANN-LA ROCHE INC. 2001-08-14 US disclosed
US-6268499-B1 USEFUL AS RENIN INHIBITORS HOFFMAN-LA ROCHE INC. 2001-07-31 US disclosed
WO-2000063173-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PIPERIDINES F. HOFFMANN-LA ROCHE AG (CH) 2000-10-26 WO disclosed
CN-1245800-A Method for preparing substituted piperidine HOFFMANN LA ROCHE (CH) 2000-03-01 CN disclosed
CN-1245805-A Method for preparing substituted piperidine-epoxide HOFFMANN LA ROCHE (CH) 2000-03-01 CN disclosed
EP-0979824-A1 Process for the preparation of substituted piperidine-epoxides F. HOFFMANN-LA ROCHE AG (CH) 2000-02-16 EP disclosed
EP-0979819-A1 Process for the production of substituted 3-hydroxypiperidines F. HOFFMANN-LA ROCHE AG (CH) 2000-02-16 EP disclosed